Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 246 member A (FAM246A) is a protein-coding gene with limited functional characterization. It is primarily referenced by its gene or protein name, and there is no published evidence that FAM246A functions as a receptor, enzyme, or other canonical therapeutic target class. The only disease association currently reported is with autism spectrum disorder. There are no documented drugs, mechanisms of action, or established biomarker or safety data for FAM246A. Its best-characterized relationship is as a paralog of the gene FAM246B[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 246 member A (FAM246A).